Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy

Autor:	Satoshi Mizobuchi, Kenta Kubota, Shohei Makino, Norihiko Obata, T Yokoyama, Yuji Miyatake, Shinichiro Izuta, Moritoki Egi, H Kita, Takuyo Misumi
Jazyk:	angličtina
Rok vydání:	2015
Předmět:	medicine.drug_class business.industry medicine.medical_treatment Anesthesia Anticoagulant Poster Presentation medicine Renal replacement therapy Heparin Critical Care and Intensive Care Medicine Nafamostat mesilate business medicine.drug
Zdroj:	Critical Care
ISSN:	1466-609X 1364-8535
Popis:	For continuous renal replacement therapy (CRRT), continuous administration of anticoagulant would be necessary to prevent the circuit clotting. Nafamostat mesilate (NM) is commonly used as its anticoagulant in Japan, although unfractionated heparin (UFH) is the most frequently used anticoagulant internationally. There is little study to compare the risk and benefit of NM with UFH as an anticoagulant during CRRT.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f10e25bc3dd11c5106413a07a0dfbe05 http://europepmc.org/articles/PMC4470927 Zobrazit plný text záznamu Full text from SpringerLink